Medicenna Therapeutics Corp. (TSX: MDNA)
Canada
· Delayed Price · Currency is CAD
1.320
+0.020 (1.54%)
Jan 30, 2025, 4:00 PM EST
Medicenna Therapeutics Employees
Medicenna Therapeutics had 16 employees as of March 31, 2024. The number of employees did not change compared to the previous year.
Employees
16
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-1.67M CAD
Market Cap
101.68M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Green Thumb Industries | 4,561 |
WELL Health Technologies | 1,507 |
dentalcorp Holdings | 9,900 |
Curaleaf Holdings | 5,650 |
Trulieve Cannabis | 5,400 |
Sienna Senior Living | 12,263 |
Cronos Group | 356 |
Extendicare | 23,000 |
Medicenna Therapeutics News
- 6 weeks ago - Medicenna Presents Preclinical Data on MDNA11 as First Step to Shrink Tumors Before Surgery and Prevent Metastasis at the 2024 San Antonio Breast Cancer Symposium (SABCS) - GlobeNewsWire
- 2 months ago - Medicenna Provides Clinical Update and Announces First Complete Responder in MDNA11 and KEYTRUDA® (pembrolizumab) Combination Dose Escalation Arm of the ABILITY-1 Study - GlobeNewsWire
- 2 months ago - Updated MDNA11 Monotherapy and Combination Clinical Data from the Ongoing Phase 1/2 ABILITY-1 Study to be Presented at the 2024 Immunotherapy Bridge Conference - GlobeNewsWire
- 2 months ago - Medicenna Presents Preclinical Data on MDNA11 and Bizaxofusp at the 2024 Annual Meeting of the Society for Neuro-Oncology (SNO) - GlobeNewsWire
- 2 months ago - Medicenna Therapeutics GAAP EPS of -C$0.05 - Seeking Alpha
- 2 months ago - Medicenna Reports Second Quarter Fiscal 2025 Financial Results and Corporate Update - GlobeNewsWire
- 2 months ago - Medicenna Announces Upcoming Presentations at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO) and the 2024 San Antonio Breast Cancer Symposium (SABCS) - GlobeNewsWire
- 2 months ago - Medicenna Presents Preclinical Data from its Anti-PD1-IL-2 BiSKIT and IL-2 Super Agonist Programs at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) - GlobeNewsWire